BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10890192)

  • 21. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
    Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
    Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Homeoproteins and pituitary adenoma].
    Barlier A; Pellegrini-Bouiller I; Gunz G; Jaquet P; Enjalbert A
    Ann Endocrinol (Paris); 1997; 58(1):3-10. PubMed ID: 9207961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
    Herman V; Drazin NZ; Gonsky R; Melmed S
    J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MSX1 in human normal pituitaries and pituitary adenomas.
    Mizokami Y; Egashira N; Takekoshi S; Itoh J; Itoh Y; Osamura RY; Matsumae M
    Endocr Pathol; 2008; 19(1):54-61. PubMed ID: 18379900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.
    Ruebel KH; Leontovich AA; Jin L; Stilling GA; Zhang H; Qian X; Nakamura N; Scheithauer BW; Kovacs K; Lloyd RV
    Endocrine; 2006 Jun; 29(3):435-44. PubMed ID: 16943582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas.
    Asa SL; Puy LA; Lew AM; Sundmark VC; Elsholtz HP
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1275-80. PubMed ID: 8077321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and genetic characterization of the porcine Prophet of Pit-1 pituitary transcription factor.
    Sloop KW; McCutchan Schiller A; Smith TP; Blanton JR; Rohrer GA; Meier BC; Rhodes SJ
    Mol Cell Endocrinol; 2000 Oct; 168(1-2):77-87. PubMed ID: 11064154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of GATA-2 in human pituitary adenomas.
    Umeoka K; Sanno N; Osamura RY; Teramoto A
    Mod Pathol; 2002 Jan; 15(1):11-7. PubMed ID: 11796836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture.
    Matsuno A; Sasaki T; Mochizuki T; Fujimaki T; Sanno N; Osamura Y; Teramoto A; Kirino T
    Acta Neurochir (Wien); 1996; 138(8):1002-7. PubMed ID: 8890999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas.
    Qian ZR; Asa SL; Siomi H; Siomi MC; Yoshimoto K; Yamada S; Wang EL; Rahman MM; Inoue H; Itakura M; Kudo E; Sano T
    Mod Pathol; 2009 Mar; 22(3):431-41. PubMed ID: 19136928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
    Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
    BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy?
    Beuschlein F; Hancke K; Petrick M; Göbel H; Honegger J; Reincke M
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):214-8. PubMed ID: 15891957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.
    Asa SL; Bamberger AM; Cao B; Wong M; Parker KL; Ezzat S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2165-70. PubMed ID: 8964846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 gene mutations in pituitary adenomas: rare events.
    Levy A; Hall L; Yeudall WA; Lightman SL
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.
    Sanno N; Teramoto A; Matsuno A; Osamura RY
    Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous gsp mutation renders ion channels of human somatotroph adenoma cells unresponsive to growth hormone-releasing hormone.
    Yasufuku-Takano J; Takano K; Takei T; Fukumoto S; Teramoto A; Takakura K; Yamashita N; Fujita T
    Endocrinology; 1999 May; 140(5):2018-26. PubMed ID: 10218950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.